286 related articles for article (PubMed ID: 24305048)
1. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression.
Kumar MS; Armenteros-Monterroso E; East P; Chakravorty P; Matthews N; Winslow MM; Downward J
Nature; 2014 Jan; 505(7482):212-7. PubMed ID: 24305048
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
Sun X; Xu M; Liu H; Ming K
Mol Med Rep; 2017 Sep; 16(3):3557-3564. PubMed ID: 28714014
[TBL] [Abstract][Full Text] [Related]
3. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.
Lee YS; Dutta A
Genes Dev; 2007 May; 21(9):1025-30. PubMed ID: 17437991
[TBL] [Abstract][Full Text] [Related]
4. MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs.
Ochieng JK; Kundu ST; Bajaj R; Leticia Rodriguez B; Fradette JJ; Gibbons DL
Oncogene; 2020 Oct; 39(43):6719-6732. PubMed ID: 32963352
[TBL] [Abstract][Full Text] [Related]
5. AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.
Tien JC; Chugh S; Goodrum AE; Cheng Y; Mannan R; Zhang Y; Wang L; Dommeti VL; Wang X; Xu A; Hon J; Kenum C; Su F; Wang R; Cao X; Shankar S; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33972443
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.
Willenbrock S; Wagner S; Reimann-Berg N; Moulay M; Hewicker-Trautwein M; Nolte I; Murua Escobar H
PLoS One; 2014; 9(6):e98788. PubMed ID: 24914948
[TBL] [Abstract][Full Text] [Related]
7. Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo.
Segal M; Biscans A; Gilles ME; Anastasiadou E; De Luca R; Lim J; Khvorova A; Slack FJ
Mol Ther Nucleic Acids; 2020 Mar; 19():267-277. PubMed ID: 31855835
[TBL] [Abstract][Full Text] [Related]
8. Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition.
Bosson AD; Zamudio JR; Sharp PA
Mol Cell; 2014 Nov; 56(3):347-359. PubMed ID: 25449132
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of a novel tumor-homing cell-penetrating peptide for drug delivery in TGFBR3 high-expressing tumors.
Wu YJ; Lei J; Zhao J; Cao XW; Wang FJ
Chem Biol Drug Des; 2023 Dec; 102(6):1421-1434. PubMed ID: 37620132
[TBL] [Abstract][Full Text] [Related]
10. Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts.
Quinn JJ; Jones MG; Okimoto RA; Nanjo S; Chan MM; Yosef N; Bivona TG; Weissman JS
Science; 2021 Feb; 371(6532):. PubMed ID: 33479121
[TBL] [Abstract][Full Text] [Related]
11. Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories.
Hynds RE; Frese KK; Pearce DR; Grönroos E; Dive C; Swanton C
Open Biol; 2021 Jan; 11(1):200247. PubMed ID: 33435818
[TBL] [Abstract][Full Text] [Related]
12. Retraction Note: microRNA-18a from M2 Macrophages Inhibits TGFBR3 to Promote Nasopharyngeal Carcinoma Progression and Tumor Growth via TGF-β Signaling Pathway.
Peng Y; Li X; Liu H; Deng X; She C; Liu C; Wang X; Liu A
Nanoscale Res Lett; 2023 Feb; 18(1):26. PubMed ID: 36853476
[No Abstract] [Full Text] [Related]
13. Retraction: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression.
Kumar MS; Armenteros-Monterroso E; East P; Chakravorty P; Matthews N; Winslow MM; Downward J
Nature; 2015 Jul; 523(7560):370. PubMed ID: 26061768
[No Abstract] [Full Text] [Related]
14. The multilayered complexity of ceRNA crosstalk and competition.
Tay Y; Rinn J; Pandolfi PP
Nature; 2014 Jan; 505(7483):344-52. PubMed ID: 24429633
[TBL] [Abstract][Full Text] [Related]
15. Aberrant ceRNA activity drives lung cancer.
Tay Y; Karreth FA; Pandolfi PP
Cell Res; 2014 Mar; 24(3):259-60. PubMed ID: 24525785
[TBL] [Abstract][Full Text] [Related]
16. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.
Karreth FA; Reschke M; Ruocco A; Ng C; Chapuy B; Léopold V; Sjoberg M; Keane TM; Verma A; Ala U; Tay Y; Wu D; Seitzer N; Velasco-Herrera Mdel C; Bothmer A; Fung J; Langellotto F; Rodig SJ; Elemento O; Shipp MA; Adams DJ; Chiarle R; Pandolfi PP
Cell; 2015 Apr; 161(2):319-32. PubMed ID: 25843629
[TBL] [Abstract][Full Text] [Related]
17. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance.
Denzler R; Agarwal V; Stefano J; Bartel DP; Stoffel M
Mol Cell; 2014 Jun; 54(5):766-76. PubMed ID: 24793693
[TBL] [Abstract][Full Text] [Related]
18. MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.
Alam M; Ahmad R; Rajabi H; Kufe D
Mol Cancer Res; 2015 Mar; 13(3):449-60. PubMed ID: 25368430
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer: A surprising competitor.
McCarthy N
Nat Rev Cancer; 2014 Feb; 14(2):73. PubMed ID: 24457413
[No Abstract] [Full Text] [Related]
20. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer.
Xia T; Liao Q; Jiang X; Shao Y; Xiao B; Xi Y; Guo J
Sci Rep; 2014 Aug; 4():6088. PubMed ID: 25124853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
